Treatment of the psychiatric problems associated with fragile X syndrome.

Treatment of the psychiatric problems associated with fragile X syndrome.

Item
http://www.wikidata.org/entity/Q38324675
Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesFragile X Proteins FMRP and FXR2P Control Synaptic GluA1 Expression and Neuronal Maturation via Distinct Mechanisms.Fragile X Syndrome: Prevalence, Treatment, and Prevention in ChinaMinocycline causes widespread cell death and increases microglial labeling in the neonatal mouse brain.MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndromeAutism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment.Simvastatin inhibits protein isoprenylation in the brain.Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome.The Emerging Field of Epitranscriptomics in Neurodevelopmental and Neuronal Disorders.Reducing histone acetylation rescues cognitive deficits in a mouse model of Fragile X syndrome.
P2860

Treatment of the psychiatric problems associated with fragile X syndrome.

Item
http://www.wikidata.org/entity/Q38324675
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Treatment of the psychiatric problems associated with fragile X syndrome.
@en
type
label
Treatment of the psychiatric problems associated with fragile X syndrome.
@en
prefLabel
Treatment of the psychiatric problems associated with fragile X syndrome.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Treatment of the psychiatric problems associated with fragile X syndrome.
@en
P2093
P2860
P304
P31
P356
10.1097/YCO.0000000000000131
P433
P478
P577
P698
P932